Legal & General Group Plc Takes Position in Transcat, Inc. $TRNS

Legal & General Group Plc acquired a new stake in shares of Transcat, Inc. (NASDAQ:TRNS) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 6,193 shares of the scientific and technical instruments company’s stock, valued at approximately $575,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of TRNS. Deutsche Bank AG increased its holdings in Transcat by 4.6% in the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock worth $400,000 after purchasing an additional 312 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after purchasing an additional 325 shares in the last quarter. Swiss National Bank boosted its stake in shares of Transcat by 2.2% during the fourth quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock valued at $1,039,000 after purchasing an additional 400 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Transcat by 8.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock worth $299,000 after purchasing an additional 432 shares during the last quarter. Finally, Diversified Trust Co grew its holdings in shares of Transcat by 8.8% during the first quarter. Diversified Trust Co now owns 5,495 shares of the scientific and technical instruments company’s stock worth $404,000 after purchasing an additional 444 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Insider Activity at Transcat

In other Transcat news, Director Christopher P. Gillette sold 504 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the sale, the director owned 200 shares of the company’s stock, valued at approximately $18,846. This represents a 71.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Craig Cairns bought 1,050 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were purchased at an average cost of $93.97 per share, with a total value of $98,668.50. Following the transaction, the director directly owned 1,480 shares in the company, valued at approximately $139,075.60. This trade represents a 244.19% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 1.80% of the company’s stock.

Transcat Trading Down 2.0%

NASDAQ TRNS opened at $83.74 on Wednesday. The business’s 50-day moving average price is $89.04 and its two-hundred day moving average price is $82.95. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $100.00. The firm has a market capitalization of $783.81 million, a PE ratio of 226.32 and a beta of 0.68. The company has a current ratio of 2.49, a quick ratio of 2.11 and a debt-to-equity ratio of 0.36.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The company had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. On average, analysts expect that Transcat, Inc. will post 1.74 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a report on Tuesday, August 25th. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Northland Securities cut shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a research report on Wednesday, August 5th. Finally, Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Transcat presently has an average rating of “Reduce” and an average price target of $95.00.

Transcat Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.